Key result
Dyslipidemia was highly prevalent (68.7%) among adults in Ulaanbaatar, Mongolia, with only 34.7% aware of their condition and 8.3% receiving statin treatment.
Why the study?
The prevalence of dyslipidemia has continued to increase in recent decades in Mongolia, but little is known regarding its awareness, treatment, and control.
Cross-Sectional (n=326)
The study reveals a high prevalence of dyslipidemia (68.7%) among adults in Ulaanbaatar, Mongolia, with low awareness (34.7%) and treatment rates (8.3%), highlighting a significant gap in cardiovascular prevention.
High dyslipidemia burden with low awareness and statin use signals prevention gaps in Mongolia; leaves open effects on regional CVD outcomes.
Objective: The prevalence of dyslipidemia continues to increase in recent decades in Mongolia; however, little is known about awareness, treatment, and control of dyslipidemia. The aim of this study was to assess the awareness, treatment, and control of dyslipidemia in adults in Ulaanbaatar, Mongolia. Methods: This cross-sectional study was conducted between June 2017 and March 2018. A total of 326 people in Ulaanbaatar participated in this study. Results: Out of the 326 participants, 224 (68.7%, 64.9 in females; 75% in males) had dyslipidemia, and around the one third 113 (34,7%) were aware of the condition. Out of the 224 dyslipidemia individuals, only 27 (8.3%) were on statin treatment. Among those individuals receiving treatment, 19 (70.4%) serum lipid level was under the desired level. Conclusion: Our study revealed an alarmingly high prevalence of dyslipidemia, low level of awareness, insufficient treatment, yet a comparatively high level of control of dyslipidemia among the adults aged 20- 69 in Ulaanbaatar relative to some other countries. The awareness, treatment, and control of dyslipidemia in the rural parts of Mongolia are unknown.
No takes yet. Share an insight, caveat, or question.
Unurjargal et al. (2019) conducted a cross-sectional in Dyslipidemia (n=326). Dyslipidemia was highly prevalent (68.7%) among adults in Ulaanbaatar, Mongolia, with only 34.7% aware of their condition and 8.3% receiving statin treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: